Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'pramipexole' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 118 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Emilien, G; Durlach, C; Aveaux, D; Maloteaux, JM
      Dopamine D-3 agonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    2. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    3. Weiner, WJ; Factor, SA; Jankovic, J; Hauser, RA; Tetrud, JW; Waters, CH; Shulman, LM; Glassman, PM; Beck, B; Paume, D; Doyle, C
      The long-term safety and efficacy of pramipexole in advanced Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    4. Larsen, JP; Tandberg, E
      Sleep disorders in patients with Parkinson's disease - Epidemiology and management

      CNS DRUGS
    5. Weimerskirch, PR; Ernst, ME
      Newer dopamine agonists in the treatment of restless legs syndrome

      ANNALS OF PHARMACOTHERAPY
    6. Lieberman, A; Minagar, A; Pinter, MM
      The efficacy of pramipexole in the treatment of Parkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    7. Zafonte, RD; Lexell, J; Cullen, N
      Possible applications for dopaminergic agents following traumatic brain injury: Part 2

      JOURNAL OF HEAD TRAUMA REHABILITATION
    8. Hogl, B; Seppi, K; Brandauer, E; Wenning, G; Poewe, W
      Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy: Placebo-controlled, polysomnographic case report

      MOVEMENT DISORDERS
    9. Tanaka, K; Miyazaki, I; Fujita, N; Haque, ME; Asanuma, M; Ogawa, N
      Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist

      NEUROCHEMICAL RESEARCH
    10. Jankovic, J; Tan, EK
      Choosing dopamine agonists in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    11. Micallef-Roll, J; Rihet, P; Hasbroucq, T; Possamai, C; Blin, O
      Levodopa-induced drowsiness in healthy volunteers: Results of a choice reaction time test combined with a subjective evaluation of sedation

      CLINICAL NEUROPHARMACOLOGY
    12. Levant, B; McCarson, KE
      D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function

      NEUROSCIENCE LETTERS
    13. Mungersdorf, M; Sommer, U; Sommer, M; Reichmann, H
      High-dose therapy with ropinirole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    14. Hanna, PA; Ratkos, L; Ondo, WG; Jankovic, J
      Switching from pergolide to pramipexole in patients with Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    15. Tuite, P; Ebbitt, B
      Dopamine agonists

      SEMINARS IN NEUROLOGY
    16. Perugi, G; Toni, C; Ruffolo, G; Frare, F; Akiskal, H
      Adjunctive dopamine agonists in treatment-resistant bipolar II depression:an open case series

      PHARMACOPSYCHIATRY
    17. Etminan, M; Samii, A; Takkouche, B; Rochon, PA
      Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease - A meta-analysis of randomised controlled trials

      DRUG SAFETY
    18. Rascol, O; Ferreira, J; Montastruc, JL
      Abnormal daytime somnolence, "sleep attacks", and antiparkinson drugs

      REVUE NEUROLOGIQUE
    19. Miranda, M; Diaz, V; Venegas, P; Villagra, R
      Sleep attacks induced by anti-Parkinson disease drugs

      REVISTA MEDICA DE CHILE
    20. Hogl, B; Wetter, TC; Trenkwalder, C
      Pathophysiology, clinical picture, and therapy for sleep disturbances in Parkinson's disease

      NERVENARZT
    21. Rice, JE; Thompson, PD
      Movement disorders I: Parkinsonism and the akinetic-rigid syndromes

      MEDICAL JOURNAL OF AUSTRALIA
    22. Kakimura, J; Kitamura, Y; Takata, K; Kohno, Y; Nomura, Y; Taniguchi, T
      Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Rajaraman, V; Jack, D; Adamovich, SV; Hening, W; Sage, J; Poizner, H
      A novel quantitative method for 3D measurement of Parkinsonian tremor

      CLINICAL NEUROPHYSIOLOGY
    24. Stern, MB
      The early treatment of Parkinson's disease: levodopa, dopamine agonists orboth

      PARKINSONISM & RELATED DISORDERS
    25. Ferreira, JJ; Rascol, O
      Drug-related sleep disturbances and Parkinson's disease: effects of dopaminergic antiparkinsonian drugs on sleep and wakefulness

      EUROPEAN JOURNAL OF NEUROLOGY
    26. de Yebenes, JG
      Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    27. Shulman, LM
      How to succeed in using dopamine agonists in Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    28. Hubble, JP
      Pre-clinical studies of pramipexole: clinical relevance

      EUROPEAN JOURNAL OF NEUROLOGY
    29. Montplaisir, J; Denesle, R; Petit, D
      Pramipexole in the treatment of restless legs syndrome: a follow-up study

      EUROPEAN JOURNAL OF NEUROLOGY
    30. Lambert, D; Waters, CH
      Comparative tolerability of the newer generation antiparkinsonian agents

      DRUGS & AGING
    31. Young, LR; Justice, LN
      Parkinson's disease: Focus on management alternatives

      AMERICAN JOURNAL OF MANAGED CARE
    32. Ahlskog, JE
      Treatment of motor complications in advancing Parkinson's disease: Which drugs and when?

      FORMULARY
    33. Scheife, RT; Schumock, GT; Burstein, A; Gottwald, MD; Luer, MS
      Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    34. Finotti, N; Castagna, L; Moretti, A; Marzatico, F
      Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

      PHARMACOLOGICAL RESEARCH
    35. Rye, DB; Bliwise, DL; Dihenia, B; Gurecki, P
      Daytime sleepiness in Parkinson's disease

      JOURNAL OF SLEEP RESEARCH
    36. Walters, AS; Mandelbaum, DE; Lewin, DS; Kugler, S; England, SJ; Miller, M
      Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD

      PEDIATRIC NEUROLOGY
    37. Hauser, RA; Gauger, L; Anderson, WM; Zesiewicz, TA
      Pramipexole-induced somnolence and episodes of daytime sleep

      MOVEMENT DISORDERS
    38. Lachenmayer, L
      Parkinson's disease and the ability to drive

      JOURNAL OF NEUROLOGY
    39. Zou, LL; Xu, J; Jankovic, J; He, Y; Appel, SH; Le, WD
      Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice

      NEUROSCIENCE LETTERS
    40. Winkelmann, J; Trenkwalder, C
      Therapy of restless legs syndrome

      AKTUELLE NEUROLOGIE
    41. Vu, TQ; Ling, ZD; Ma, SY; Robie, HC; Tong, CW; Chen, EY; Lipton, JW; Carvey, PM
      Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine

      JOURNAL OF NEURAL TRANSMISSION
    42. Maj, J; Rogoz, Z; Margas, W; Kata, M; Dziedzicka-Wasylewska, M
      The effect of repeated treatment with pramipexole on the central dopamine D-3 system

      JOURNAL OF NEURAL TRANSMISSION
    43. Pinter, MM; Rutgers, AWF; Hebenstreit, E
      An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    44. Prikhojan, A; Brannan, T; Yahr, MD
      Comparative effects of repeated administration of dopamine agonists on circling behavior in rats

      JOURNAL OF NEURAL TRANSMISSION
    45. Le, WD; Jankovic, J; Xie, W; Appel, SH
      Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

      JOURNAL OF NEURAL TRANSMISSION
    46. Ryan, M; Slevin, JT; Wells, A
      Non-ergot dopamine agonist-induced sleep attacks

      PHARMACOTHERAPY
    47. Lam, YWF
      Clinical pharmacology of dopamine agonists

      PHARMACOTHERAPY
    48. LeWitt, PA
      New drugs for the treatment of Parkinson's disease

      PHARMACOTHERAPY
    49. Tanner, CM
      Dopamine agonists in early therapy for Parkinson disease - Promise and problems

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    50. Moller, JC; Stiasny, K; Cassel, W; Peter, JH; Kruger, HP; Oertel, WH
      "Sleep attacks" in parkinsonian patients: a side effect of nonergoline dopamine agonists or a class effect of dopamimetic agents?

      NERVENARZT
    51. Brooks, DJ
      Dopamine agonists: their role in the treatment of Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    52. Hubner, H; Haubmann, C; Utz, W; Gmeiner, P
      Conjugated enynes as nonaromatic catechol bioisosteres: Synthesis, bindingexperiments, and computational studies of novel dopamine receptor agonistsrecognizing preferentially the D-3 subtype

      JOURNAL OF MEDICINAL CHEMISTRY
    53. van Vliet, LA; Rodenhuis, N; Wikstrom, H; Pugsley, TA; Serpa, KA; Meltzer, LT; Heffner, TG; Wise, LD; Lajiness, ME; Huff, RM; Svensson, K; Haenen, GRMM; Bast, A
      Thiazoloindans and thiazolobenzopyrans: A novel class of orally active central dopamine (partial) agonists

      JOURNAL OF MEDICINAL CHEMISTRY
    54. Kitamura, Y; Shimohama, S; Akaike, A; Taniguchi, T
      The parkinsonian models: Invertebrates to mammals

      JAPANESE JOURNAL OF PHARMACOLOGY
    55. Ferger, B; Teismann, P; Mierau, J
      The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study

      BRAIN RESEARCH
    56. Takata, K; Kitamura, Y; Kakimura, J; Kohno, Y; Taniguchi, T
      Increase of Bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole

      BRAIN RESEARCH
    57. Kujawa, K; Leurgans, S; Raman, R; Blasucci, L; Goetz, CG
      Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease

      ARCHIVES OF NEUROLOGY
    58. Thorpy, M; Ehrenberg, BL; Hening, WA; Mahowald, M; Malow, BA; Phillips, B; Richardson, C; Wellbery, C; Hallett, M; Kiley, IP; McCutcheon, C; Rogus, S
      Restless legs syndrome: Detection and management in primary care

      AMERICAN FAMILY PHYSICIAN
    59. Cummings, JL; Masterman, DL
      Depression in patients with Parkinson's disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    60. Picchietti, DL; Underwood, DJ; Farris, WA; Walters, AS; Shah, MM; Dahl, RE; Trubnick, LJ; Bertocci, MA; Wagner, M; Hening, WA
      Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder

      MOVEMENT DISORDERS
    61. Montastruc, JL; Rascol, O; Senard, JM
      Treatment of Parkinson's disease should begin with a dopamine agonist

      MOVEMENT DISORDERS
    62. Ceballos-Baumann, AO
      New aspects in the treatment of Parkinson's disease

      NERVENHEILKUNDE
    63. Kunig, G; Pogarell, O; Moller, JC; Delf, M; Oertel, WH
      Pramipexole, a nonergot dopamine agonist, is effective against rest tremorin intermediate to advanced Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    64. Rascol, O
      Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    65. Maj, J; Rogoz, Z; Skuza, G
      The anticataleptic effect of 7-OH-DPAT: are dopamine D-3 receptors involved?

      JOURNAL OF NEURAL TRANSMISSION
    66. Matzanke, N; Lowe, W; Perachon, S; Sokoloff, P; Schwartz, JC; Stark, H
      Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D-3-receptor ligands

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    67. Benes, H; Kurella, B; Kummer, J; Kazenwadel, J; Selzer, R; Kohnen, R
      Rapid onset of action of levodopa in restless legs syndrome: A double-blind, randomized, multicenter, crossover trial

      SLEEP
    68. Chesson, AL; Wise, M; Davila, D; Johnson, S; Littner, M; Anderson, WM; Hartse, K; Rafecas, J
      Practice parameters for the treatment of Restless Legs Syndrome and periodic limb movement disorder

      SLEEP
    69. Ohnmacht, U; Trankle, C; Mohr, K; Gmeiner, P
      [H-3]Pramipexole: a selective radioligand for the high affinity dopamine D-2 receptor in bovine striatal membranes

      PHARMAZIE
    70. Galvez-Jimenez, N; Khan, T; Hanson, M
      Restless legs syndrome

      NEUROLOGY
    71. Goetz, CG; Blasucci, L; Stebbins, GT
      Switching dopamine agonists in advanced Parkinson's disease - Is rapid titration preferable to slow?

      NEUROLOGY
    72. Arnold, G; Kupsch, A
      High dose therapy of a patient with Parkinson's disease with the novel dopamine agonist Pramipexole allows reduction of L-dopa down to nil

      NERVENARZT
    73. Vincenzi, FF; Hinds, TR
      Stobadine: Bellwether of a broader view of drug actions

      LIFE SCIENCES
    74. Zou, LL; Jankovic, J; Rowe, DB; Xie, WJ; Appel, SH; Le, WD
      Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

      LIFE SCIENCES
    75. Bennett, JP; Piercey, MF
      Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    76. Pinter, MM; Pogarell, O; Oertel, WH
      Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    77. Lorenc-Koci, E; Wolfarth, S
      Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    78. Perachon, S; Schwartz, JC; Sokoloff, P
      Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D-1, D-2 and D-3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    79. Coldwell, MC; Boyfield, I; Brown, T; Hagen, JJ; Middlemiss, DN
      Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D-2(long), D-3 and D-4.4 receptors expressed in Chinese hamster ovary cells

      BRITISH JOURNAL OF PHARMACOLOGY
    80. Jankovic, J
      New and emerging therapies for Parkinson disease

      ARCHIVES OF NEUROLOGY
    81. WERMUTH L
      A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTICENTER STUDY OF PRAMIPEXOLE IN ADVANCED PARKINSONS-DISEASE

      European journal of neurology
    82. STOCCHI F
      DOPAMINE AGONISTS IN PARKINSONS-DISEASE - WHAT IS THEIR ROLE IN EARLYTREATMENT

      CNS drugs
    83. VONVOIGTLANDER PF; FICI GJ; ALTHAUS JS
      PHARMACOLOGICAL APPROACHES TO COUNTER THE TOXICITY OF DOPA

      Amino acids
    84. LAGOS P; SCORZA C; MONTI JM; JANTOS H; REYESPARADA M; SILVEIRA R; PONZONI A
      EFFECTS OF THE D-3 PREFERRING DOPAMINE AGONIST PRAMIPEXOLE ON SLEEP AND WAKING, LOCOMOTOR-ACTIVITY AND STRIATAL DOPAMINE RELEASE IN RATS

      European neuropsychopharmacology
    85. Kulisevsky, J; Lopez-Villegas, D; Garcia-Sanchez, C; Barbanoj, M; Gironell, A; Pascual-Sedano, B
      A six-month study of pergolide and levodopa in de novo Parkinson's diseasepatients

      CLINICAL NEUROPHARMACOLOGY
    86. POGARELL O; OERTEL WH
      NEW DOPAMINE AGONISTS FOR THE TREATMENT OF PARKINSONS-DISEASE

      Aktuelle Neurologie
    87. Brecht, HM
      A comparison of dopamine agonists

      AKTUELLE NEUROLOGIE
    88. YAMAMOTO M
      DO DOPAMINE AGONISTS PROVIDE NEUROPROTECTION

      Neurology
    89. WALLACE DR; OWENS J; BOOZE RM
      [H-3](-7-OH-DPAT AND [H-3]PRAMIPEXOLE BINDING IN THE STRATUM AND NUCLEUS-ACCUMBENS OF SPRAGUE-DAWLEY AND FISCHER-344 RATS())

      Life sciences (1973)
    90. BARTOSZYK GD
      ANXIOLYTIC EFFECTS OF DOPAMINE-RECEPTOR LIGANDS - I - INVOLVEMENT OF DOPAMINE AUTORECEPTORS

      Life sciences
    91. CASSARINO DS; FALL CP; SMITH TS; BENNETT JP
      PRAMIPEXOLE REDUCES REACTIVE OXYGEN SPECIES PRODUCTION IN-VIVO AND IN-VITRO AND INHIBITS THE MITOCHONDRIAL PERMEABILITY TRANSITION PRODUCEDBY THE PARKINSONIAN NEUROTOXIN METHYLPYRIDINIUM ION

      Journal of neurochemistry
    92. KITAMURA Y; KAKIMURA J; TANIGUCHI T
      PROTECTIVE EFFECT OF TALIPEXOLE ON MPTP-TREATED PLANARIAN, A UNIQUE PARKINSONIAN WORM MODEL

      Japanese Journal of Pharmacology
    93. GOTTWALD MD; BAINBRIDGE JL; DOWLING GA; AMINOFF MJ; ALLDREDGE BK
      NEW PHARMACOTHERAPY FOR PARKINSONS-DISEASE

      The Annals of pharmacotherapy
    94. LEWITT PA
      NEW OPTIONS FOR TREATMENT OF PARKINSONS-DISEASE

      Bailliere's clinical neurology
    95. CAINE SB; KOOB GF; PARSONS LH; EVERITT BJ; SCHWARTZ JC; SOKOLOFF P
      D-3 RECEPTOR TEST IN-VITRO PREDICTS DECREASED COCAINE SELF-ADMINISTRATION IN RATS

      NeuroReport
    96. KASPER S; BARNAS C; HEIDEN A; VOLZ HP; LAAKMANN G; ZEIT H; PFOLZ H
      PRAMIPEXOLE AS ADJUNCT TO HALOPERIDOL IN SCHIZOPHRENIA SAFETY AND EFFICACY

      European neuropsychopharmacology
    97. MAJ J; ROGOZ Z; SKUZA G; KOLODZIEJCZYK K
      ANTIDEPRESSANT EFFECTS OF PRAMIPEXOLE, A NOVEL DOPAMINE-RECEPTOR AGONIST

      Journal of neural transmission
    98. CARVEY PM; PIERI S; LING ZD
      ATTENUATION OF LEVODOPA-INDUCED TOXICITY IN MESENCEPHALIC CULTURES BYPRAMIPEXOLE

      Journal of neural transmission
    99. KITAMURA Y; KOHNO Y; NAKAZAWA M; NOMURA Y
      INHIBITORY EFFECTS OF TALIPEXOLE AND PRAMIPEXOLE ON MPTP-INDUCED DOPAMINE REDUCTION IN THE STRIATUM OF C57BL 6N MICE/

      Japanese Journal of Pharmacology
    100. DOMINO EF; NI LS; ZHANG HL; KOHNO Y; SASA M
      TALIPEXOLE OR PRAMIPEXOLE COMBINATIONS WITH CHLORO-APB (SKF-82958) INMPTP-INDUCED HEMIPARKINSONIAN MONKEYS

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 20:50:47